GT
IDXX icon

Glenmede Trust’s Idexx Laboratories IDXX Stock Holding History

Glenmede Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.49M Sell
15,104
-2,797
-16% -$1.79M 0.04% 372
2025
Q4 		$12.1M Buy
+17,901
New +$12.2M 0.06% 290
2025
Q1 		$1.17M Buy
2,780
+419
+18% +$182K 0.01% 660
2024
Q4 		$976K Buy
2,361
+487
+26% +$214K 0.01% 719
2024
Q3 		$947K Buy
1,874
+48
+3% +$23.3K ﹤0.01% 735
2024
Q2 		$890K Buy
1,826
+380
+26% +$191K ﹤0.01% 719
2024
Q1 		$781K Buy
1,446
+78
+6% +$42.6K ﹤0.01% 779
2023
Q4 		$759K Sell
1,368
-2,227
-62% -$1.05M ﹤0.01% 778
2023
Q3 		$1.57M Buy
3,595
+2,247
+167% +$1.12M 0.01% 563
2023
Q2 		$674K Hold
1,348
– – ﹤0.01% 756
2023
Q1 		$674K Buy
1,348
+99
+8% +$47.4K ﹤0.01% 758
2022
Q4 		$510K Buy
1,249
+153
+14% +$59.4K ﹤0.01% 831
2022
Q3 		$356K Sell
1,096
-340
-24% -$125K ﹤0.01% 900
2022
Q2 		$503K Sell
1,436
-358
-20% -$146K ﹤0.01% 852
2022
Q1 		$980K Sell
1,794
-72
-4% -$37.9K ﹤0.01% 728
2021
Q4 		$1.23M Buy
1,866
+52
+3% +$32.6K 0.01% 685
2021
Q3 		$1.13M Buy
1,814
+37
+2% +$24.9K 0.01% 671
2021
Q2 		$1.12M Buy
1,777
+35
+2% +$19.3K 0.01% 673
2021
Q1 		$852K Sell
1,742
-42
-2% -$21K ﹤0.01% 721
2020
Q4 		$891K Buy
1,784
+21
+1% +$9.4K ﹤0.01% 699
2020
Q3 		$692K Buy
1,763
+534
+43% +$197K ﹤0.01% 699
2020
Q2 		$404K Sell
1,229
-389
-24% -$113K ﹤0.01% 819
2020
Q1 		$421K Hold
1,618
– – ﹤0.01% 953
2019
Q4 		$421K Sell
1,618
-494
-23% -$130K ﹤0.01% 953
2019
Q3 		$573 Buy
2,112
+1,372
+185% +$382K ﹤0.01% 856
2019
Q2 		$202 Sell
740
-87
-11% -$21.4K ﹤0.01% 1155
2019
Q1 		$184 Buy
827
+142
+21% +$29.3K ﹤0.01% 1201
2018
Q4 		$126 Sell
685
-52
-7% -$10.7K ﹤0.01% 1286
2018
Q3 		$183K Sell
737
-20
-3% -$4.86K ﹤0.01% 1175
2018
Q2 		$165K Sell
757
-3,603
-83% -$742K ﹤0.01% 1115
2018
Q1 		$681K Hold
4,360
– – ﹤0.01% 861
2017
Q4 		$681K Sell
4,360
-39
-0.9% -$6.14K ﹤0.01% 861
2017
Q3 		$683K Buy
4,399
+3,567
+429% +$564K ﹤0.01% 840
2017
Q2 		$127K Hold
832
– – ﹤0.01% 1328
2017
Q1 		$127K Sell
832
-186
-18% -$25.6K ﹤0.01% 1328
2016
Q4 		$118K Buy
1,018
+452
+80% +$51.6K ﹤0.01% 1355
2016
Q3 		$63K Sell
566
-41
-7% -$4.32K ﹤0.01% 1535
2016
Q2 		$56K Buy
607
+167
+38% +$14.3K ﹤0.01% 1535
2016
Q1 		$34K Buy
440
+15
+4% +$1.08K ﹤0.01% 1647
2015
Q4 		$30K Buy
425
+42
+11% +$3K ﹤0.01% 1733
2015
Q3 		$28K Sell
383
-371
-49% -$26.6K ﹤0.01% 1783
2015
Q2 		$48K Sell
754
-3,976
-84% -$275K ﹤0.01% 1642
2015
Q1 		$365K Sell
4,730
-150
-3% -$11.7K ﹤0.01% 1086
2014
Q4 		$361K Sell
4,880
-26
-0.5% -$1.82K ﹤0.01% 1087
2014
Q3 		$289K Buy
4,906
+26
+0.5% +$1.64K ﹤0.01% 1070
2014
Q2 		$325K Hold
4,880
– – ﹤0.01% 1014
2014
Q1 		$296K Sell
4,880
-1,630
-25% -$97.1K ﹤0.01% 1054
2013
Q4 		$346K Hold
6,510
– – ﹤0.01% 973
2013
Q3 		$324K Buy
6,510
+100
+2% +$4.81K ﹤0.01% 978
2013
Q2 		$287K Buy
+6,410
New +$280K ﹤0.01% 968

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Glenmede Trust's IDXX Position: Q1 2026 in Review

Glenmede Trust reduced its Idexx Laboratories (IDXX) stake by 16% in Q1 2026, selling an estimated $1.79M and leaving 15,104 shares worth $8.49M. The position accounts for 0.04% of the portfolio, ranked #372.

Glenmede Trust first reported a position in IDXX in Q2 2013 and has held it in 50 quarters since. The position peaked at $12.1M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Glenmede Trust held 15,104 shares of Idexx Laboratories worth $8.49M as of Q1 2026.
  • Glenmede Trust sold 2,797 Idexx Laboratories shares in Q1 2026, an estimated $1.79M.
  • Idexx Laboratories made up 0.04% of Glenmede Trust's portfolio in Q1 2026, its #372 holding.
  • Glenmede Trust first reported a position in Idexx Laboratories in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's Idexx Laboratories position peaked at $12.1M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.